Avanos Medical (AVNS) Total Current Liabilities (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Total Current Liabilities data on file, last reported at $131.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 4.37% year-over-year to $131.2 million; the trailing twelve-month figure through Mar 2026 stood at $131.2 million (down 4.37% YoY), and the FY2025 full-year result was $165.2 million, changed 0.42% from the prior year.
• Total Current Liabilities retreated to $131.2 million in Q1 2026, from $165.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $234.6 million in Q4 2023 to a low of $131.2 million in Q1 2026.
• A 5-year average of $170.0 million and a median of $162.3 million in 2022 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities surged 37.21% in 2022 and slumped 35.35% in 2025, its largest moves.
• Tracing AVNS's Total Current Liabilities over 5 years: stood at $191.0 million in 2022, then gained by 22.83% to $234.6 million in 2023, then slipped by 29.28% to $165.9 million in 2024, then decreased by 0.42% to $165.2 million in 2025, then slipped by 20.58% to $131.2 million in 2026.
• Business Quant data shows AVNS's Total Current Liabilities at $131.2 million in Q1 2026, $165.2 million in Q4 2025, and $147.9 million in Q3 2025.